|
|
||||||||
From Discoveries in Sight, Devers Eye Institute, Portland, Oregon.
| Abstract |
|---|
|
|
|---|
METHODS. The method of constant stimuli (MOCS) was used to examine matched test locations with both SAP and FDT perimetry stimuli in a group of eight normal individuals and seven patients with glaucoma. Subjects were tested weekly at three predetermined visual field loci for 5 consecutive weeks. Frequency-of-seeing (FOS) curves were generated and used to quantify threshold sensitivity (50% seen on FOS, in decibels), intratest variability (FOS interquartile range, in decibels), and intertest variability (interquartile range of weekly repeated threshold determinations, in decibels).
RESULTS. In patients with glaucoma, SAP intra- and intertest variabilities were found to increase with sensitivity reductions, as previously reported. FDT perimetry revealed that both intra- and intertest variability components did not appreciably change with reductions in sensitivity. With the measurement scales used in this investigation, both intra- and intertest variability components were significantly greater for SAP than for FDT perimetry (P < 0.001 and P = 0.003, respectively). Intratest variability exceeded intertest variability for both SAP (P = 0.001) and FDT perimetry (P < 0.001).
CONCLUSIONS. For both SAP and FDT perimetry, variability occurring within a single test session contributed more to total variability than between-session variability. When the measurement scales available on commercial instrumentation were used, FDT perimetry exhibited significantly less variability than SAP, especially within regions of visual field sensitivity loss. FDT perimetry therefore shows promise as an effective test for detecting progressive glaucomatous visual field loss, although prospective longitudinal validation is still required to determine sensitivity to change.
| Introduction |
|---|
|
|
|---|
FDT perimetry has been shown to exhibit high discriminatory power for detection of early glaucoma8 9 10 11 and is clinically desirable, because the test is resilient to refractive errors and blur and has a large dynamic range, and because threshold test strategies are short in duration. In addition, in patients with glaucoma, it has been reported that testretest variability that occurs with FDT perimetry does not increase as much with increases in defect severity as with SAP. Provided FDT perimetry demonstrates adequate sensitivity to change, its beneficial variability characteristics imply that it may be useful for the detection of glaucomatous visual field progression.12
Two variability components have been described for threshold perimetry: within a single test session (intratest) and between test sessions (intertest). Tests that exhibit lower amounts of either of these variability components are likely to be of greater clinical value, because they may be better able to differentiate progressive visual function loss from pathophysiologic variability. Quantification of testretest variability obtained from clinically applied thresholding algorithms has been reported for both SAP and FDT perimetry,12 13 but does not provide information on the described individual variability components. Although more rigorous psychophysical evaluations of intratest variability for both normal and glaucomatous visual fields have been reported for SAP,14 15 16 17 18 this information does not yet exist for FDT perimetry. The use of these more rigorous psychophysical test procedures has not been applied to determination of intertest variability for either SAP or FDT perimetry. Data in previous reports on intertest variability for SAP were obtained by using mathematical methods of extraction from threshold estimates derived from repeated staircase procedures,19 20 21 22 rather than by more extensive psychophysical approaches, such as longitudinal evaluation of precise threshold measurements using repeated frequency-of-seeing (FOS) curves.
The purpose of this investigation was to precisely quantify and compare intra- and intertest variability components for both SAP and FDT perimetry in a small group of normal individuals and in a group of patients with glaucoma.
| Materials and Methods |
|---|
|
|
|---|
A fellowship-trained glaucoma specialist diagnosed glaucoma in patients on the basis of optic nerve head assessment and visual field status. For patients with glaucoma, the range of mean deviations (MDs) on HFA program 24-2 (full threshold) examination was from -3.36 to -8.56 dB (mean, -5.77 dB). No patients with glaucoma were receiving miotic glaucoma therapy, and natural pupil size was used. Each normal individual had MD, pattern standard deviation (PSD), and corrected pattern standard deviation (CPSD) within normal population limits (P > 0.05); a normal glaucoma hemifield test result; no history of ophthalmic or systemic disease; and normal findings in an ocular examination. All subjects had best corrected visual acuity of 20/30 or better.
Informed consent was obtained from each participant in accordance with the Declaration of Helsinki. The study was approved by the institutional review board of Legacy Health System.
Perimetric Instrumentation
Matched test locations were examined for both conventional and
frequency-doubled stimuli. Subjects wore appropriate refractive
corrections for both tests. SAP testing was performed on an HFA (model
610; Humphrey) that was externally driven by a computer running custom
software. Test conditions identical with routine testing were used:
size III test target, 200-msec stimulus duration, and 31.5-apostilb
(asb; 10 candelas [cd]/m2) background
illumination. Frequency-doubling stimuli were presented on a 21-in.
video monitor (Multiscan G500; Sony, Tokyo, Japan) driven by a video
board (VSG2/3; Cambridge Research Systems, Rochester, UK).
Frequency-doubling stimuli were generated using the same spatiotemporal
properties used by the commercially available FDT perimeter (0.25
cyc/deg spatial frequency sinusoidal waveforms and 25-Hz counterphase
flicker). Mean luminance was 50 cd/m2. Other
properties of frequency-doubling stimuli were also controlled to
emulate the commercially available FDT instrumentation, including test
target configuration (square 10° x 10°) and stimulus duration
(720-msec total stimulus duration, with 160-msec linear on-ramp from
0% to tested contrast, 400-msec at test contrast, and 160-msec
off-ramp returning to 0% contrast).
Procedure
The MOCS was used to examine three test locations between
fixation and 20° in each subject. All subjects received MOCS training
in a separate session (on different days) before data collection. In
the group of normal individuals, test locations were chosen so that
equal numbers of superior and inferior locations were used, with equal
spread among eccentricities, thereby providing data representative of
locations throughout tested areas of the visual field. In patients with
glaucoma, test locations were selected in visual field areas that
ranged between normal and moderately damaged (total deviation, up to
-10 dB) on the basis of the most recent SAP examination. This
total-deviation criterion was selected to avoid a floor effect that may
have artifactually truncated variability measurements, had deeper
defects been included.
Each subject was tested at these same three visual field loci weekly on five consecutive occasions. For each test location and test session, the MOCS range was centered using an average of two threshold estimates obtained with a 4- to 2-dB double-reversal staircase algorithm. For MOCS, seven stimulus luminances were examined, three each side of estimated threshold. Step sizes between stimuli were adjusted to approach both 0% and 100% seen, and ranged from 1 to 3 dB. Twenty stimuli were presented at each stimulus luminance. Stimuli were randomized between luminance levels and test location. Order of testing at each session was determined randomly for each subject. Timing of test during the day was not controlled. Subjects were given short rests at regular intervals, if required.
It is important to recognize that although SAP and FDT perimetry both make measurements of sensitivity in decibels, the two measurement scales differ conceptually and so have different ranges and number of intervals. Care should be taken to note that HFA decibels and FDT decibels are not equivalent. In this study, SAP sensitivity measurements used the proprietary logarithmic HFA scale of retinal sensitivity. Each interval on this scale represents a 0.1-log unit (1 dB) attenuation of the brightest stimulus that the HFA can present (10,000 asb). Higher numbers on this scale therefore represent dimmer stimuli (thus denoting higher sensitivity) and vice versa. This HFA decibel scale has a range of 4 log units (or 40 dB), with 0 dB being equivalent to a 10,000-asb increment stimuli and 40 dB being 1 asb on a 31.5-asb background.23 The scale used for FDT perimetry in this study is also logarithmic but is a decibels scale of FDT stimulus contrast sensitivity: 1 dB = log(1/contrast threshold) · 10. An FDT stimulus that is visible at the maximum stimulus contrast of 100% corresponds to an FDT scale measurement of 0 dB ([log(1/0)] · 10), whereas a stimulus perceived at a contrast of 1% is equivalent to a FDT sensitivity of 20 dB ([log(1/0)] · 10). The FDT scale therefore has a range of 2 log units (20-dB intervals) to represent the stimulus contrast range from 1% to 100% and uses 1-dB scale intervals. Because 1 dB on the HFA measurement scale is therefore fundamentally different from 1 dB on the FDT measurement scale, this difference precludes comparison of the instruments. In this study it was critical that comparison between the variability of the instruments be based on the number of scale intervals that characterize variability, although, regrettably, both instruments use the same decibel nomenclature.
It is also important to note that the FDT scale used in this experiment is not the same as the scale of the commercially available FDT device, which has been adjusted by a proprietary multiplicative factor to produce an HFA-equivalent range, although it uses the same number of scale intervals, as described earlier.
Data Analysis
FOS curves were constructed by fitting data using a cumulative
gaussian function (Tablecurve 2D; SPSS Science, Chicago, IL). FOS
curves were used to quantify threshold sensitivity (50% seen on FOS,
in decibels), intratest variability (FOS interquartile range, in
decibels) and intertest variability (interquartile range of five
repeated threshold sensitivity determinations over 4 weeks, in
decibels). Other groups have used interquartile range to quantify
intratest variability,15
16
and this was selected for use
in this study, because it represents a quantity that is common to the
measurement scale of the instrumentation, thereby providing clinical
context.
The mean threshold and mean intratest variability over five repeat visits were used in all analyses. It was assumed that by use of a relatively short duration for data collection (4 weeks) any change in threshold over the examination period could be attributed to intertest variability, rather than glaucomatous progression.
Data analysis was performed by computer (Intercooled Stata 5.0; Stata, College Station, TX, and SigmaStat 2.0; SPSS Science).
| Results |
|---|
|
|
|---|
|
|
|
|
0.6 dB (95% CI,
0.420.83) for every 1 dB of sensitivity loss (Table 2)
. However, no such relationship was observed at normal sensitivity
levels. The relationship between sensitivity and intratest variability
for FDT perimetry is shown in Figure 4B (also Table 2
) and demonstrates
that intratest variability was independent of sensitivity for both
normal individuals and patients with glaucoma.
|
|
Figures 5A
and 5B
show the relationship between sensitivity and intertest
variability for SAP and FDT perimetry (Table 3)
. From Figure 5A
it can be seen that SAP intertest variability behaved
in a manner similar to that described for intratest variability, in
that the amount of variability was independent of sensitivity in normal
individuals but was dependent on sensitivity in patients with glaucoma.
This relationship between sensitivity and intertest variability in
patients with glaucoma was such that intertest variability increased by
0.2 dB for every 1 dB of glaucomatous sensitivity loss. For FDT
perimetry (Fig. 5B)
, intertest variability was independent of
sensitivity and remained at
0.75 dB throughout the measured range of
sensitivities.
|
|
| Discussion |
|---|
|
|
|---|
In clinical environments, tests with less variability are therefore more desirable because they do not require as much sensitivity shift to denote significant change or progression. In this view, previous investigators have reported that high-pass resolution perimetry (HRP) has lower variability than SAP15 26 and Chauhan et al.27 have reported that this results in HRPs being able to detect glaucomatous visual field progression an average of 12 to 18 months earlier than SAP. However, it is important to recognize that low variability does not ensure that a test is sensitive to change. Prospective longitudinal investigations are still needed to establish sensitivity to validate the technique as a clinically reliable means of detecting progressive loss.
The experimental design used in this study provided robust measurements of threshold and intratest variability, by using FOS curves. Our MOCS procedure was performed for both SAP and FDT perimetry to provide a quantitative comparison of their variability characteristics, while also yielding the first FOS curve analysis for the FDT stimulus. In addition, an alternative method of intertest variability quantification was achieved by collection of data for FOS curve construction at the same test locations on a number of visits. Measurement of intertest variability in this manner was considered preferable to the previously reported mathematical extraction techniques that were based on data gathered using staircase strategies and therefore do not have the accuracy and precision of FOS curves.28 29 It was interesting to note that these MOCS-based sensitivity estimates were, in some cases, lower than anticipated from the total-deviation inclusion criterion. This finding may be the result of error in threshold estimation by either strategy, although the rigorous nature of MOCS dictates that overestimation of sensitivity by the 4- to 2-dB double-reversal adaptive staircase strategy is the most parsimonious explanation.29
The results of this study are in agreement with reports that describe significantly increased levels of intra- and intertest variability with SAP sensitivity reductions in glaucoma.13 14 16 18 20 For FDT perimetry, although average levels of intra-and intertest variability were greater in patients with glaucoma than in normal individuals, the differences between the groups were small and were found to be independent of sensitivity. The amounts of both variability components in this sample were substantially and significantly less in FDT perimetry than in SAP. Practically, these findings imply that FDT perimetry may be a valid tool for detection of change in clinical situations, provided it can be prospectively shown to exhibit similar or better sensitivity to change than SAP.
A number of investigators have questioned the cause of increased variability in damaged visual field areas in SAP.12 18 30 Given that artifactual fixation errors have been ruled out,31 32 it may be postulated that factors responsible for increased variability include greater background variability noisefor example, atypical firing characteristics of damaged retinal ganglion cells or reduced pooling of ganglion cell response signal caused by lower ganglion cell densities resulting from glaucomatous cell death.33 Reports that SAP variability is independent of the cause of optic nerve damage18 and is reduced with larger stimuli30 are consistent with the latter of these hypotheses. For these reasons it has been suggested that the larger FDT perimetry stimulus size (10° compared with the 0.43° used in SAP) contributes to its lower variability,12 despite the differences in relative density between sparse My-cells purported to produce the frequency-doubling percept and abundant parvocellular ganglion cells that detect SAP stimuli. The rationale underlying use of different stimulus sizes for SAP and FDT perimetry in this study was to permit generalization of the findings to clinical situations. Recent studies have shown that higher spatial resolution FDT perimetry can be performed reliably using 4° diameter stimuli in a pattern similar to the 24-2 used by the HFA.34 Studies evaluating the variability characteristics of these smaller stimuli are under way.
In this investigation, intratest variability was found to be significantly greater than intertest variability for both SAP and FDT perimetry. It is particularly important to emphasize this result, because many modern studies that quantify perimetric variability use testretest analyses. Testretest methodology represents a compound measurement of intra- and intertest variability, because results are obtained using thresholding strategies used by commercially available instrumentation, such as the adaptive staircase for SAP13 and the modified binary search35 36 for FDT perimetry.8 The results obtained by these strategies are therefore affected by both intra- and intertest variability components. For this reason, testretest analysis may be mistakenly interpreted as a quantification of intertest variability alone. By demonstrating that intratest variability is a significantly larger variability component than intertest variability, intratest variability therefore contributes more to testretest variability. It should also be noted that testretest analyses are subject to variability induced by the thresholding strategy. Thresholding strategies that exhibit equal or less intratest variability, such as those based on maximum likelihood37 (e.g., the Swedish Interactive threshold algorithm [SITA]38 or ZEST for FDT perimetry39 ) may be of greater value for monitoring progression.
Although the comparison of the two perimetric techniques performed in this investigation suggests that FDT perimetry demonstrates more favorable variability characteristics than SAP, it is important to recognize that this finding may have resulted from differences in measurement scales between the two techniques. The measurement scale used for FDT perimetry was purposely designed to be equivalent to the 20-interval scale used by the commercial instrumentation, but was compared in this investigation with the 40-interval HFA scale. Therefore, although FDT perimetry appeared to exhibit less variability with this coarse measurement scale, use of such a scale may be less sensitive to progressive loss than a finer scale. The issue of whether FDT perimetry is more sensitive to change than SAP requires resolution by prospective longitudinal clinical investigation. In addition, the possibility that use of an equal number of scale intervals by both techniques may yield minimal differences in variability components should also be considered.
In summary, this study shows that under test and measurement scale conditions similar to those used in clinical situations, FDT perimetry exhibited significantly lower intra- and intertest variability than SAP. FDT perimetry may therefore be preferable for monitoring individuals with glaucoma, because less sensitivity change is required to exceed variability. However, longitudinal investigations are needed to establish the sensitivity of FDT perimetry to change. Also, intratest variability contributes more to total variability than intertest variability, implying that thresholding strategies with lower intratest variability used with either SAP or FDT perimetry will be able to differentiate significant change from variability. Thresholding strategies with lower intratest variability may have preferable discriminatory power for detection of progressive defects.
| Footnotes |
|---|
Submitted for publication June 12, 2000; revised August 31 and December 13, 2000; accepted January 12, 2001.
Commercial relationships policy: F (CAJ); C (CAJ); N (all others).
Corresponding author: Paul G. D. Spry, Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK. pgds{at}hotmail.com
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. Racette, F. A. Medeiros, L. M. Zangwill, D. Ng, R. N. Weinreb, and P. A. Sample Diagnostic Accuracy of the Matrix 24-2 and Original N-30 Frequency-Doubling Technology Tests Compared with Standard Automated Perimetry Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Salvetat, M. Zeppieri, L. Parisi, and P. Brusini Rarebit Perimetry in Normal Subjects: Test Retest Variability, Learning Effect, Normative Range, Influence of Optical Defocus, and Cataract Extraction Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5320 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bagga, W. J. Feuer, and D. S. Greenfield Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry. Arch Ophthalmol, February 1, 2006; 124(2): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Artes, D. M. Hutchison, M. T. Nicolela, R. P. LeBlanc, and B. C. Chauhan Threshold and Variability Properties of Matrix Frequency-Doubling Technology and Standard Automated Perimetry in Glaucoma Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2451 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Anderson, C. A. Johnson, M. Fingeret, J. L. Keltner, P. G. D. Spry, M. Wall, and J. S. Werner Characteristics of the Normative Database for the Humphrey Matrix Perimeter Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1540 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Haymes, D. M. Hutchison, T. A. McCormick, D. K. Varma, M. T. Nicolela, R. P. LeBlanc, and B. C. Chauhan Glaucomatous Visual Field Progression with Frequency-Doubling Technology and Standard Automated Perimetry in a Longitudinal Prospective Study Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 547 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bjerre, J. R. Grigg, N. R. A. Parry, and D. B. Henson Test-Retest Variability of Multifocal Visual Evoked Potential and SITA Standard Perimetry in Glaucoma Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4035 - 4040. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Anderson and C. A. Johnson Frequency-Doubling Technology Perimetry and Optical Defocus Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4147 - 4152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Anderson Spatial Resolution of the Tendency-Oriented Perimetry Algorithm Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1962 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. McKendrick, A. J. Anderson, C. A. Johnson, and B. Fortune Appearance of the Frequency Doubling Stimulus in Normal Subjects and Patients with Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1111 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P G D Spry, C A Johnson, A M McKendrick, and A Turpin Measurement error of visual field tests in glaucoma Br. J. Ophthalmol., January 1, 2003; 87(1): 107 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gardiner and D. P. Crabb Examination of Different Pointwise Linear Regression Methods for Determining Visual Field Progression Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1400 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Gardiner and D P Crabb Frequency of testing for detecting visual field progression Br. J. Ophthalmol., May 1, 2002; 86(5): 560 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Turpin, A. M. McKendrick, C. A. Johnson, and A. J. Vingrys Performance of Efficient Test Procedures for Frequency-Doubling Technology Perimetry in Normal and Glaucomatous Eyes Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Turpin, A. M. McKendrick, C. A. Johnson, and A. J. Vingrys Development of Efficient Threshold Strategies for Frequency Doubling Technology Perimetry Using Computer Simulation Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 322 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. McKendrick, G. A. Cioffi, and C. A. Johnson Short-Wavelength Sensitivity Deficits in Patients With Migraine Arch Ophthalmol, February 1, 2002; 120(2): 154 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. D. Spry, C. A. Johnson, A. B. Bates, A. Turpin, and B. C. Chauhan Spatial and Temporal Processing of Threshold Data for Detection of Progressive Glaucomatous Visual Field Loss Arch Ophthalmol, February 1, 2002; 120(2): 173 - 180. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||